Pathology of malignant mesothelioma

被引:199
作者
Attanoos, RL [1 ]
Gibbs, AR [1 ]
机构
[1] LLANDOUGH HOSP, DEPT HISTOPATHOL, PENARTH, S GLAM, WALES
关键词
malignant mesothelioma; pleura; peritoneum; adenomatoid tumour; well-differentiated papillary mesothelioma; multicystic mesothelioma; asbestos;
D O I
10.1046/j.1365-2559.1997.5460776.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The diagnosis of malignant mesothelioma can pose several problems to the surgical pathologist. First, the morphological appearances of the tumour are known to be diverse with mimicry of a range of both reactive and neoplastic conditions. Second, due to the relative inaccessibility of the serosa, biopsy material is often scanty and fragmentary, producing a plethora of interpretive ambiguities. Third, adjunct techniques such as mucin histochemistry and immunohistochemistry, whilst useful in excluding malignant mesothelioma have little role in confirming the diagnosis. The accurate diagnosis of diffuse malignant mesothelioma is important for two reasons: (1) In relation to prognosis as it has an almost invariable fatal outcome, which contrasts with the other mesothelial neoplasms such as the benign adenomatoid tumour and the borderline malignant tumours, namely the well-differentiated papillary mesothelioma and multicystic mesothelioma; (2) In relation to occupational-related compensation claims following asbestos exposure. This review summarizes the aetiology of asbestos-induced neoplasia, possible mechanisms of tumour development and highlights potential diagnostic pitfalls.
引用
收藏
页码:403 / 418
页数:16
相关论文
共 138 条
[1]  
ACHESON ED, 1982, BRIT J IND MED, V39, P344
[2]  
ACHESON ED, 1981, LANCET, V2, P1403
[3]  
ALLISON AC, 1967, JNCI-J NATL CANCER I, V38, P567
[4]  
AMIN KM, 1995, AM J PATHOL, V146, P344
[5]   Primary epithelioid haemangioendothelioma of the peritoneum: An unusual mimic of diffuse malignant mesothelioma [J].
Attanoos, RL ;
Dallimore, NS ;
Gibbs, AR .
HISTOPATHOLOGY, 1997, 30 (04) :375-377
[6]   CD44H expression in reactive mesothelium, pleural mesothelioma and pulmonary adenocarcinoma [J].
Attanoos, RL ;
Webb, R ;
Gibbs, AR .
HISTOPATHOLOGY, 1997, 30 (03) :260-263
[7]   Mesothelioma-binding antibodies: Thrombomodulin, OV 632 and HBME-1 and their use in the diagnosis of malignant mesothelioma [J].
Attanoos, RL ;
Goddard, H ;
Gibbs, AR .
HISTOPATHOLOGY, 1996, 29 (03) :209-215
[8]   PRESENCE OF ASBESTOS BODIES IN ORGANS OTHER THAN THE LUNG [J].
AUERBACH, O ;
CONSTON, AS ;
GARFINKEL, L ;
PARKS, VR ;
KASLOW, HD ;
HAMMOND, EC .
CHEST, 1980, 77 (02) :133-137
[9]   A NOVEL BIOTINYLATED PROBE SPECIFIC FOR HYALURONATE - ITS DIAGNOSTIC-VALUE IN DIFFUSE MALIGNANT MESOTHELIOMA [J].
AZUMI, N ;
UNDERHILL, CB ;
KAGAN, E ;
SHEIBANI, K .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1992, 16 (02) :116-121
[10]   PLEURAL MULTICYSTIC MESOTHELIAL PROLIFERATION - THE SO-CALLED MULTICYSTIC MESOTHELIOMA [J].
BALL, NJ ;
URBANSKI, SJ ;
GREEN, FHY ;
KIESER, T .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1990, 14 (04) :375-378